why choose us

Clinical Trials Search

Showing 8,820 of 132,366 result(s)
Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization

Status: COMPLETED

Condition: Acute Coronary Syndrome

Interventions: OCT- or IVUS-guided JINS approach in DES implantation (DES types including Healing-Targeted SUPREME;Infinity Sirolimus-Eluting Stent, GuReater™ S

Date: 2023-08-21

Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery

Status: COMPLETED

Condition: Whey Protein

Interventions: Participants are given Isolated whey protein supplement in evening before surgery and first day of post operation to compare with standard operative c

Date: 2023-08-21

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Status: COMPLETED

Condition: Chronic Plaque Psoriasis

Interventions: Study participants will receive placebo subcutaneously at pre-specified time points in the placebo arm as comparator and in the bimekizumab arm to mai

Date: 2023-08-21

The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

Status: COMPLETED

Condition: Dermal Hypersensitivity Reaction

Interventions:

Patients will start by getting dupilumab 600 milligram (mg) subcutaneously at week 0, followed by 300 mg every 2 weeks starting at week 2. The last

Date: 2023-08-21

Aquacel Hypersensitivity Dressing in TJAs

Status: COMPLETED

Condition: Contact Allergic Dermatitis

Interventions: Patients will be recruited into the study after completing a standard questionnaire for pre-operative enrollment.
After meeting inclusion criteri

Date: 2023-08-21

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Status: COMPLETED

Condition: COVID-19 Respiratory Infection

Interventions: The self-collected Labcorp COVID-19+Flu+RSV Test Home Collection Kit results as generated by the commercially available Labcorp Seasonal Respiratory V

Date: 2023-08-21

Aquacel Hypersensitivity Dressing in TJAs

Status: COMPLETED

Condition: Contact Allergic Dermatitis

Interventions: Patients will be recruited into the study after completing a standard questionnaire for pre-operative enrollment.
After meeting inclusion criteri

Date: 2023-08-21

A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

Status: COMPLETED

Condition: Type 2 Diabetes

Interventions: Administered orally

Date: 2023-08-21

A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Status: COMPLETED

Condition: Esophageal Cancer
Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma by

Interventions: DRUG: LBL-007 - LBL-007 will be administered at a standard dose intravenously.
DRUG: Tislelizumab - Tislelizumab will be administered at a standa

Date: 2023-08-21

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Status: COMPLETED

Condition: Cystic Fibrosis Lung
Respiratory Infections, Recurrent, Chronic
Pseudomonas Aeruginosa

Interventions: DRUG: RSP-1502 - RSP-1502 is a sterile, preservative free solution to be administered by inhalation via a nebulizer. Each dose of RSP-1502 contains th

Date: 2023-08-21